These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 8881162)
21. Rapid re-enlargement of a macroprolactinoma after initial shrinkage in a young woman treated with bromocriptine. Adler I; Barsi P; Czirják S; Varga I; Gergics P; Jakab C; Rácz K Gynecol Endocrinol; 2005 Jun; 20(6):317-21. PubMed ID: 16019380 [TBL] [Abstract][Full Text] [Related]
22. [Prolactin-secreting pituitary adenomas: explorations and treatment (author's transl)]. McGregor A; Scanlon MF; Hall R Ann Med Interne (Paris); 1982; 133(1):51-7. PubMed ID: 7065590 [TBL] [Abstract][Full Text] [Related]
24. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas]. Yokoyama M No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270 [TBL] [Abstract][Full Text] [Related]
26. [Reversible blindness caused by an invasive prolactinoma]. Schöfl-Siegert B; Brabant G; von zur Mühlen A; Schöfl C Dtsch Med Wochenschr; 2001 May; 126(21):621-4. PubMed ID: 11413749 [TBL] [Abstract][Full Text] [Related]
27. SUCCESSFUL TREATMENT OF A PROLACTINOMA (CASE REPORT). Pasyechko N; Naumova L; Krytskyy T; Kulchinska V Georgian Med News; 2019 Feb; (287):26-29. PubMed ID: 30958283 [TBL] [Abstract][Full Text] [Related]
28. Giant prolactinomas larger than 60 mm in size: a cohort of massive and aggressive prolactin-secreting pituitary adenomas. Shimon I; Sosa E; Mendoza V; Greenman Y; Tirosh A; Espinosa E; Popovic V; Glezer A; Bronstein MD; Mercado M Pituitary; 2016 Aug; 19(4):429-36. PubMed ID: 27138902 [TBL] [Abstract][Full Text] [Related]
29. Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists. Hamilton DK; Vance ML; Boulos PT; Laws ER Pituitary; 2005; 8(1):53-60. PubMed ID: 16411069 [TBL] [Abstract][Full Text] [Related]
30. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors. Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702 [TBL] [Abstract][Full Text] [Related]
31. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea. Nillius SJ Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464 [TBL] [Abstract][Full Text] [Related]
32. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women. Colao A; Di Sarno A; Guerra E; De Leo M; Mentone A; Lombardi G Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):200-10. PubMed ID: 16932285 [TBL] [Abstract][Full Text] [Related]
33. [Prolactin producing hypophyseal adenoma: diagnosis and therapeutic possibilities]. Landolt AM; Froesch ER Schweiz Med Wochenschr; 1985 Jun; 115(23):803-9. PubMed ID: 4023673 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and treatment of prolactinomas. Molitch ME Adv Intern Med; 1999; 44():117-53. PubMed ID: 9929707 [No Abstract] [Full Text] [Related]
35. Disorders of prolactin secretion. Molitch ME Endocrinol Metab Clin North Am; 2001 Sep; 30(3):585-610. PubMed ID: 11571932 [TBL] [Abstract][Full Text] [Related]
36. [Some issues in the diagnosis and treatment of hyperprolactinemia]. Jin ZM Zhonghua Fu Chan Ke Za Zhi; 2008 Apr; 43(4):241-3. PubMed ID: 18843959 [No Abstract] [Full Text] [Related]